SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech failure, 2002
An SI Board Since January 2002
Posts SubjectMarks Bans
130 20 0
Emcee:  Miljenko Zuanic Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
105INSM INS-1 fails on diabetes & PCOS. Message 17975840mopgcw-9/10/2002
104Press Release Source: Genentech, Inc. Phase III Trial With Avastin in RelapsedMiljenko Zuanic-9/9/2002
103SAN DIEGO--(BUSINESS WIRE)--Sept. 5, 2002--IDEC Pharmaceuticals Corporation (Nasnigel bates-9/5/2002
102A free, open access journal, about biotech failures! jnrbm.com Only problem,aknahow-8/23/2002
101Wilder, is this what you're referring to? sim1-7/31/2002
100I've heard the cariporide Expedition cabg trial has been stopped. Can'tkeokalani'nui-7/30/2002
99Maybe not total failure. Very disappointing that the steroid withdrawal study dkeokalani'nui-7/30/2002
98HYDERABAD, India--(BUSINESS WIRE)--July 22, 2002-- Carcinogenicity studies revenigel bates-7/22/2002
97Millennium Discontinues Oral MLN977 Program -- Oral MLN977 program demonstratednigel bates-7/15/2002
96Wyeth stock sinks after study finds its drug can increase women's risk of bsim1-7/10/2002
95Additional details provided. "The news surprised investors, many of whom beaknahow-7/2/2002
94<<Sure, that probably is a dumb question but in other cases posters appearMiljenko Zuanic-7/1/2002
93Could someone comment on what the problem might be if, as stated, it is not safeaknahow-7/1/2002
92BioCryst Pharmaceuticals, Inc. Announces Preliminary Phase III Trial Results fornigel bates-6/25/2002
91ImmunoGen Takes Two Hits To Pipeline Promise By: Hollister H. Hovey, Of DOW JONECzechsinthemail-6/25/2002
90Monday June 24, 7:38 am Eastern Time Press Release SOURCE: Endo Pharmaceuticals Miljenko Zuanic-6/24/2002
89OXFORD, England, June 24 /PRNewswire-FirstCall/ -- Oxford GlycoSciences Plc (Nasnigel bates-6/24/2002
88AstraZeneca Responds To FDA Action On Supplemental New Drug Application For CASOsim1-6/21/2002
87Rick Just scanned the article perhaps they're attracted to this "The dalroi-6/19/2002
86PRCS has a trial (and molecule, IMO) go belly up, and it's up 8%. Traders cscaram(o)uche-6/19/2002
85Medigene Discontinues Etomoxir Development Definitively MUNICH -(Dow Jones)- Gekeokalani'nui-6/16/2002
84Biogen Antava was on hold too, +12 months ago, so why anyone expected miracle wiMiljenko Zuanic-6/10/2002
83Message 17582424 Monday June 10, 2:00 pm Eastern Time Press Release SOURCE: WyeMiljenko Zuanic-6/10/2002
82Interesting, but are you talking as a medical doctor or like I "only" Alfred W. Post-6/10/2002
81The whole rebif/avonex battle was hardly a contest of one superior product over mopgcw-6/10/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News